• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES U.K. LIMITED DC BEAD; EMBOLIC AGENT, HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES U.K. LIMITED DC BEAD; EMBOLIC AGENT, HCG, KRD Back to Search Results
Model Number 300-500UM
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/23/2015
Event Type  malfunction  
Event Description
This is a potential harm report rec'd from a tech via a partner organization.No procedure or pt info was provided.The report concerns an event reported post tace procedure using dc bead loaded with doxorubicin where the radiology department reported that the vial was found to contain a blue particulate.It was confirmed by the reporter that at the time of reporting the prod had already had the radio contrast added and the beads removed and injected into the pt.The reporter stated that during the procedure the blue contaminate kept getting stuck in the stopcock used to transfer the beads and drug prod.It was confirmed during the investigation that the blue containment observed in the syringe containing beads and doxorubicin solution was a fragment of a dilator which was inadvertently introduced into the prod during preparation procedure by the hospital personnel.There was no pt harm as a result of this incident.
 
Manufacturer Narrative
Dc bead with doxorubicin was reported to have been used in the treatment of this pt.The equivalent prod, lc bead, is available in the usa and is indicated for the treatment of hypervascular tumors and avms.The device has not been sent to the mfr for eval.Med assessment: whilst there was no report of pt harm it was confirmed that the particulate was likely introduced during prod preparation and therefore this is user error and needs to be reported because if this type of error were to recur it could result in serious pt harm.Investigation into this report found that the blue contaminant observed in the syringe containing beads and doxorubicin solution was a fragment of a dilator which was inadvertently introduced into the prod during preparation procedure by the hospital personnel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DC BEAD
Type of Device
EMBOLIC AGENT, HCG, KRD
Manufacturer (Section D)
BIOCOMPATIBLES U.K. LIMITED
weydon ln
farnham business park
farnham, surrey GU9 8QL
UK  GU9 8QL
Manufacturer Contact
sam temple-scotton
weydon lane
farnham business park
farnham, surrey GU9 8-QL
UK   GU9 8QL
252732732
MDR Report Key4811861
MDR Text Key5928748
Report Number3002124545-2015-00026
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
PMA/PMN Number
K094018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 05/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/26/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2016
Device Model Number300-500UM
Device Lot NumberV10406
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/27/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-